Nanollose Secures R&D Loan Facility; Shares Fall 10%
Nanollose entered into an AU$200,000 research and development loan facility with Asymmetric Innovative Finance, according to a Wednesday filing with the Australian bourse.The loan facility, secured by the biomaterials company's expected R&D tax rebate for FY24, has an annual interest rate of 16%. The funds from this loan facility have been received, the filing said.Shares of Nanollose plunged almost 10% in recent trade.